MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Why Amazon Rules Retail
- Wave of Debt Payments Facing US Government
- China Eastern to Complete Shanghai Air Buy by End '09
- JAL Slides to Record Low on Bankruptcy Jitters
- Prepare For Large Decline In Stocks, Next Year?
- Gold Will Collapse Like Oil Did in 2008: Charts
- The Social Media Gaming Threat
- Paul: Audit the Fed
- Nielsen Ratings Coming to Video Games
- How Many US Consumers Will Shop this Weekend?
- Tuesday's Heavy Dose of Data to Dictate 'Risk' Behavior
- World's Largest Share Issue Priced at Deep Discount
- Obama says Boosting US Jobs is Top Priority
- Why the Dollar Will Likely Stay Weak for Some Time
- Playboy to Outsource Most Magazine Operations: Report
- General Motors to Cut up to 9,500 Jobs in Europe
- EU Drops Proceedings Against Qualcomm
- Appeals Court Denies Microsoft's Alcatel Petition
- Can Murdoch Help Bing Challenge Google and Shift the Content Equation?
- HP's Mark Hurd
- HP Comes in As Expected; Is It Time to Buy?
- 9 Stocks That Play Rising Water Costs: Strategists
- Weis' Deal Likely Won't Change Big Money Contracts
- Gold Prices Can Double in 3 Years: Portfolio Manager
- Nov. 23: Unusual Volume Leaders
- Help Wanted—Please Run $4 Billion University
- Apple Comes to AT&T's Rescue
Text Size 
SHENZHEN, China, Nov 04, 2009 /PRNewswire-Asia-FirstCall via COMTEX/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that Mr. Ronald Ede, Chief Financial Officer, will participate in a panel discussion at the Financial Times' Global Pharmaceutical and Biotechnology Conference, which will be held at the Millennium Mayfair Hotel in London on November 17-18, 2009.
Mr. Ede will present as a guest panelist during the panel entitled "Exploring New Avenues for Innovation, Growth and Profitability -- The Role of Emerging Markets," which will take place on November 17, 2009 from 3:15-4:15 GMT.
To learn more about the Financial Times' Global Pharmaceutical and Biotechnology Conference, please visit http://www.ftconferences.com/pharmabio .
About Mindray We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets.
From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com .
For further information, please contact:
In the U.S.:
FD
Evan Smith, CFA
Tel: +1-212-850-5606
Email: evan.smith@fd.com
John Capodanno
Tel: +1-212-850-5705
Email: john.capodanno@fd.com
In China:
Cathy Gao
Tel: +86-755-2658-2518
Email: cathy.gao@mindray.com SOURCE Mindray Medical International Limited URL: http://www.mindray.com
http://ir.mindray.com
http://www.ftconferences.com/pharmabio www.prnewswire.com Copyright (C) 2009 PR Newswire. All rights reserved -0- KEYWORD: China INDUSTRY KEYWORD: HEA
MTC SUBJECT CODE: TDS
AWD
Print
Email
Data is a real-time snapshot *Data is delayed at least 15 minutes